1. ScholarBank@NUS

Alan Prem Kumar

rp02898

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
Main Affiliation
 
Faculty
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Results 141-158 of 158 (Search time: 0.016 seconds).

Issue DateTitleAuthor(s)
1412017The role of resveratrol in cancer therapyKo, J.-H; Sethi, G ; Um, J.-Y; Shanmugam, M.K ; Arfuso, F; Kumar, A.P ; Bishayee, A; Ahn, K.S
1422018The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignanciesArora, L; Kumar, A.P ; Arfuso, F; Chng, W.J ; Sethi, G 
1434-Dec-2018Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling AxisShanmugam, Muthu K ; Ahn, Kwang Seok; Hsu, Annie ; Woo, Chern Chiuh; Yuan, Yi; Tan, Kwong Huat Benny ; Chinnathambi, Arunachalam; Alahmadi, Tahani Awad; Alharbi, Sulaiman Ali; Koh, Angele Pei Fern; Arfuso, Frank; Huang, Ruby Yun-Ju; Lim, Lina HK ; Alan, Gautam Sethi ; Kumar, Alan Prem 
1442-Oct-2013Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROSWoo, C.C.; Hsu, A.; Kumar, A.P. ; Sethi, G.; Tan, K.H.B.
1452014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
615-Feb-2012Thymoquinone: Potential cure for inflammatory disorders and cancerWoo, C.C.; Kumar, A.P. ; Sethi, G.; Tan, K.H.B.
72018TIPE family of proteins and its implications in different chronic diseasesBordoloi D.; Banik K.; Shabnam B.; Padmavathi G.; Monisha J.; Arfuso F.; Dharmarajan A.; Mao X., Lim L.H.K. ; Wang L. ; Fan L. ; Hui K.M. ; Kumar A.P. ; Sethi G. ; Kunnumakkara A.B.
82019TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of AKt/mTOR/NF-κB signaling cascadeBordoloi, D.; Banik, K.; Padmavathi, G.; Vikkurthi, R.; Harsha, C.; Kishor Roy, N.; Kumar Singh, A.; Monisha, J.; Wang, H.; Prem Kumar, A. ; Kunnumakkara, A.B.
92014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G. 
1031-Oct-2021Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathwayArora, Loukik; Mohan, Chakrabhavi Dhananjaya; Yang, Min Hee; Rangappa, Shobith; Deivasigamani, Amudha; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.; Garg, Manoj; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Alahmadi, Tahani Awad; Rangappa, Kanchugarakoppal S.; Hui, Kam Man ; Sethi, Gautam ; Ahn, Kwang Seok
111-Jun-2013Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studiesShanmugam, M.K. ; Dai, X.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.
12Jul-2011Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude miceShanmugam, M.K. ; Rajendran, P.; Li, F.; Nema, T.; Vali, S.; Abbasi, T.; Kapoor, S.; Sharma, A.; Kumar, A.P. ; Ho, P.C. ; Hui, K.M.; Sethi, G.
1312-Mar-2012Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathwaysShanmugam, M.K. ; Ong, T.H.; Kumar, A.P. ; Lun, C.K.; Ho, P.C. ; Wong, P.T.H.; Hui, K.M.; Sethi, G.
142015Viperatoxin-II: A novel viper venom protein as an effective bactericidal agentSamy, R.P ; Stiles, B.G; Chinnathambi, A; Zayed, M.E; Alharbi, S.A; Franco, O.L; Rowan, E.G; Kumar, A.P ; Lim, L.H.K ; Sethi, G 
152017Wnt signaling in triple-negative breast cancerPohl, Sö.-G; Brook, N; Agostino, M; Arfuso, F; Kumar, A.P ; Dharmarajan, A
162017ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activatorJahn, A; Rane, G ; Paszkowski-Rogacz, M; Sayols, S; Bluhm, A; Han, C.-T; Draškovič, I; Londoño-Vallejo, J.A; Kumar, A.P ; Buchholz, F; Butter, F; Kappei, D 
172014γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen, K.S.; Ahn, K.S.; Ong, T.H.; Shanmugam, M.K. ; Li, F.; Yap, W.N.; Kumar, A.P. ; Fong, C.W.; Tergaonkar, V.; Hui, K.M. ; Sethi, G.
18May-2011γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agentRajendran, P.; Li, F.; Manu, K.A. ; Shanmugam, M.K. ; Loo, S.Y.; Kumar, A.P. ; Sethi, G.